peptide for weight loss retatrutide UK 2026: Phase 3 Results Phase III retatrutide study demonstrates

Ozempic is a brand-name prescription medication that was originally approved by the U.S

These receptors help with metabolism

Mounjaro/Zepbound (tirzepatide), approved dual GLP-1/GIP agonist for type 2 diabetes and obesity Recent Highlights: In April 2026, the FDA approved orforglipron (Foundayo), making it one of the first oral GLP-1 pills that can be taken any time of day and that has no food or water restrictions

Current trials have been conducted primarily in the United States, limiting ethnic diversity

GLP-1s Show Promise, but New Uses Arent Here Yet Editorial Sources and Fact-Checking GLP-1 Agonists

BBC News Online